Upstream and down-stream biopharmaceutical manufacturers

Modular Multi-functional Formulation System for Upstream & Downstream Biopharmaceutical Manufacturers

Application Overview

Biopharmaceutical production involves complex upstream and downstream processes, including cell culture, media preparation, buffer preparation, fermentation, purification, ultrafiltration, diafiltration, virus inactivation, and final drug product formulation. These processes require high sterility, stability, traceability, and flexibility. The PHARMAC Modular Multi-functional Formulation System provides a unified, scalable, and fully compliant platform that supports the entire upstream and downstream workflow.

Designed with independent, autonomous modules, the system can be freely assembled into media preparation, buffer solution, formulation mixing, filtration, temperature control, CIP/SIP, and sterile distribution units. It adapts to the strict requirements of biologics production, including antibodies, vaccines, recombinant proteins, enzymes, cell and gene therapy products, and blood products.

With integrated automation, RFID interconnection, and SCADA/MES connectivity, the system ensures full data integrity, process reproducibility, and regulatory compliance. It supports smooth scale-up from lab to pilot to commercial manufacturing, helping biopharmaceutical enterprises build flexible, efficient, and future‑proof production lines.

Core Value & Advantages

• Unified modular platform covering media/buffer preparation, formulation, filtration, and distribution.

• High sterility and sanitary design ideal for biotech drugs, antibodies, vaccines, and recombinant proteins.

• Seamless connection with bioreactors, fermentation systems, chromatography, and UF/DF equipment.

• High flexibility to adjust process flow for different products and production stages.

• Full automation, data traceability, and audit trail to meet FDA 21 CFR Part 11 and GMP.

• Rapid deployment and expansion, reducing time‑to‑market for biotech products.

• Lower TCO through module reuse, high utilization, and simplified validation.

Industry Application Value

For upstream and downstream biopharmaceutical manufacturers, this modular system effectively addresses the challenges of complex process flows, frequent product changes, strict regulatory requirements, and high investment costs. It enables flexible configuration of media and buffer preparation, drug substance formulation, and drug product finishing, allowing enterprises to respond quickly to process changes and capacity adjustments.

By improving process stability, ensuring sterility, and enhancing data traceability, the system helps improve product yield, purity, and consistency. Its scalable design supports seamless amplification from R&D to commercial production, accelerating innovation and industrialization. It is widely used in biotech enterprises, vaccine manufacturers, and cell therapy developers seeking a robust, flexible, and regulatory‑ready solution.